Información del producto
- (.+-.)-Verapamil
- 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile
- 2-(3,4-Dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]-2-(propan-2-yl)pentanenitrile
- 2-(3,4-Dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]-2-isopropylpentanenitrile
- 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxy phenyl)-2-isopropylvaleronitrile
- Cp 16533-1
- D 365
- Iproveratril
- Lekoptin
- Nsc 272306Na
- Ver más sinónimos
- R,S-Verapamil
- VPL
- Valeronitrile, 5-[(3,4-dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropyl-
- Verapamilo
- dl-Verapamil
- α-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-α-(1-methylethyl)benzeneacetonitrile
- Benzeneacetonitrile, α-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-α-(1-methylethyl)-
Verapamil is a calcium antagonist that blocks the influx of extracellular calcium and inhibits the release of calcium from intracellular storage sites. Verapamil may be used to treat hypertension, angina pectoris, and arrhythmias. This drug is also used as a diagnostic agent in studies of the cardiovascular system. Verapamil has been shown to reduce ventricular systolic dysfunction and cardiovascular morbidity in patients with chronic heart failure. The elimination half-life of verapamil ranges from 5 to 8 hours, depending on dose. It is eliminated primarily by renal excretion with less than 1% being metabolized in the liver.
Propiedades químicas
Consulta técnica sobre: 3D-FV02354 Verapamil
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.